Study guide

5.1 Tissue Doppler and Hemodynamic Sample Placement

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

5.1 Tissue Doppler and Hemodynamic Sample Placement

Key Takeaways Explain This Topic AI

TDI preserves low-velocity, high-amplitude tissue motion and requires a tissue preset, annular sample placement, and parallel apical alignment.

Mitral annular s′, e′, and a′ are distinct from transmitral E and A blood-flow velocities and retain site, rhythm, and loading limitations.

PW sample location defines the hemodynamic measurement; leaflet tips, LVOT, RVOT, pulmonary veins, and hepatic veins answer different questions.

Reposition the probe and gate when alignment or anatomy is wrong; do not use angle correction, tracing choices, or averaging to conceal a poor acquisition.

Last updated: July 2026

Tissue Doppler measures motion, not blood flow

Spectral tissue Doppler imaging, or TDI, uses Doppler principles to display the relatively low-velocity, high-amplitude motion of myocardium and valve annuli. Conventional spectral Doppler suppresses tissue signals to display faster blood flow; a TDI preset changes filters, gain, scale, and processing to preserve tissue motion. A blood-flow preset with the sample placed near an annulus does not become valid TDI, and color TDI values are not automatically interchangeable with pulsed spectral TDI values.

From a true apical window, align the cursor as parallel as possible to longitudinal annular motion. Place the pulsed sample at the septal and lateral mitral annulus, not in the leaflet tips, midmyocardium, or cavity. ASE's comprehensive adult TTE protocol describes a 5- to 10-mm sample for annular motion, a low velocity scale adjusted to enlarge the signal, and a 100-mm/sec sweep speed. Use the manufacturer and laboratory preset because systems display and filter tissue signals differently. Keep gain low enough to preserve a clear modal envelope without losing the waveform.

The principal components are s′ during systole, e′ during early diastolic relaxation, and a′ during atrial contraction. In the usual apical display, s′ is above baseline and e′ and a′ are below, although the machine's invert setting can reverse the display. Label by cardiac timing, not screen direction alone. Atrial fibrillation lacks a consistent a′, tachycardia can fuse components, pacing can alter timing, and an ectopic or postectopic beat may be unrepresentative.

Site Placement and alignment Main information and trap

Septal mitral annulus Sample at basal septal annulus in A4C; beam parallel to longitudinal motion Septal s′, e′, a′; velocity normally differs from lateral site, so site-specific interpretation matters

Lateral mitral annulus Sample at basal lateral annulus with a nonforeshortened LV Lateral velocities and averaged e′; excessive translation or poor alignment changes the peak

Lateral tricuspid annulus RV-focused A4C, sample at base of RV free wall along the annulus RV s′ supports longitudinal systolic assessment; do not treat one regional, angle-dependent value as the entire RV diagnosis

Mitral leaflet tips Small PW blood-flow sample between open leaflets, oriented with inflow E and A inflow velocities; this is not the location for e′ or a′

LVOT PW sample in laminar flow just proximal to the aortic valve, matched to the LVOT-diameter site Stroke-volume input; sampling too near the valve causes spectral broadening or acceleration

Pulmonary or hepatic vein Sample within the vein at the protocol-defined distance from its atrial or caval junction Venous phasic flow; wall motion, poor angle, and respiration can contaminate the signal

Sample placement is a hemodynamic decision

Pulsed Doppler localizes velocity to a selected range, so moving a sample a few millimeters may change the physiology being measured. Map first with 2-D and color, then place the gate where the question is defined. For mitral inflow, a 1- to 3-mm sample at the open leaflet tips records E and A. For LVOT velocity-time integral, use the center of laminar outflow about 5 mm proximal to the valve and match the diameter-measurement level. A narrow envelope with a closing click supports placement; broadening or higher velocities suggest movement too close to the valve.

For right ventricular outflow, sample just proximal to the pulmonic valve from the view with the best alignment. Pulmonary venous flow is commonly acquired roughly 1 cm into a pulmonary vein from the atrial junction, while hepatic venous flow is acquired about 1 to 2 cm from its IVC junction and observed through respiration. Exact gate sizes and required measures follow the governing protocol. Continuous-wave Doppler is chosen when the highest velocity along the whole beam is needed and range specificity is unnecessary; it should not replace PW mapping when location matters.

Do not use angle correction to rescue a poor cardiac Doppler line. Reposition the transducer, choose another window, and align the beam with motion or flow. The cosine effect underestimates velocity as alignment worsens. With TDI, a sample that straddles annulus, wall, and blood may show competing signals. With flow Doppler, an oversized gate can include adjacent acceleration or wall artifact. Optimize scale so the waveform fills the display without clipping, set baseline to reveal all components, and trace the dense modal edge rather than noise.

Interpret the acquisition before the number

Mitral E/e′ combines transmitral blood velocity with annular tissue velocity, but a ratio is only as sound as both acquisitions. Use representative beats under comparable rhythm and loading, preserve septal and lateral labels, and follow current diastolic algorithms rather than diagnosing filling pressure from one ratio. Annular calcification, mitral surgery or prosthesis, regional dysfunction, conduction abnormalities, and constriction can limit assumptions. TDI e′ is less load sensitive than mitral E, not load independent.

For RV TDI, current ASE right-heart guidance places a small sample at the basal RV free wall along the lateral tricuspid annulus in an RV-focused view, with the contraction axis within about 20 degrees of the beam. S′ is the peak systolic velocity, but translation, tethering, severe tricuspid regurgitation, pacing, and loading affect it. Integrate it with RV size, fractional area change, TAPSE, strain, and clinical context in later interpretation.

Before saving, confirm site, label, sweep speed, scale, gain, complete waveform, ECG timing, rhythm, and representative beats. If lateral e′ is unexpectedly lower than septal e′, inspect the image and sample first instead of swapping labels or averaging blindly. Reacquisition is the quality response to questionable placement; a plausible numeric value is not proof of a valid signal.

Gate first, number second

Identify the anatomic site and physiologic question before placing the PW sample. A clean tracing from the wrong location is a precisely recorded wrong answer.